aTyr Pharma Q1 EPS $(0.17) Beats $(0.19) Estimate

aTyr Pharma (NASDAQ: ATYR) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.19) by 10.53 percent. This is a 26.09 percent increase over losses of $(0.23) per share from the same period last year.